Contrast Induced Nephropathy (CIN) Completed Phase 2 Trials for Acetazolamide (DB00819)

Also known as: Contrast Induced Nephropathy

IndicationStatusPhase
DBCOND0066353 (Contrast Induced Nephropathy (CIN))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00634491Comparison Between Effect of Acetazolamide and NaHco3 in Prevention of Contrast NephropathyPrevention